Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System.

@article{Ioannou2016EffectivenessOS,
  title={Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System.},
  author={George N. Ioannou and Lauren A. Beste and Michael F Chang and Pamela K. Green and Elliott Lowy and Judith I. Tsui and Feng Jie Su and Kristin Berry},
  journal={Gastroenterology},
  year={2016},
  volume={151 3},
  pages={457-471.e5}
}
BACKGROUND & AIMS We investigated the real-world effectiveness of sofosbuvir, ledipasvir/sofosbuvir, and paritaprevir/ritonavir/ombitasvir and dasabuvir (PrOD) in treatment of different subgroups of patients infected with hepatitis C virus (HCV) genotypes 1, 2, 3, or 4. METHODS We performed a retrospective analysis of data from 17,487 patients with HCV infection (13,974 with HCV genotype 1; 2131 with genotype 2; 1237 with genotype 3; and 135 with genotype 4) who began treatment with… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 56 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 36 references

Effectiveness of simeprevir plus sofosbuvir, with or without ribavirin, in real-world patients with HCV genotype 1 infection

MS Sulkowski, HE Vargas, AM Di Bisceglie
Gastroenterology • 2016

Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society • 2016

of Veterans Affairs

US Departmen
Health services research and development. http://www.hsrd.research.va. gov/for_researchers/vinci/cdw.cfm. Accessed February 10, • 2016

recommendations for testing, managing, and treating hepatitis C

HCV Guidance
AASLD and IDSA. Available at: http://www.hcvguidelines.org. Accessed January 25, • 2016

Similar Papers

Loading similar papers…